Clinicopathologic features of post-transplant lymphoproliferative disorders arising after pediatric small bowel transplant.

Abstract

Few studies examined the clinicopathologic features of PTLD arising in pediatric SBT patients. Particularly, the association between ATG and PTLD in this population has not been described. Retrospective review of 81 pediatric patient charts with SBT--isolated or in combination with other organs--showed a PTLD incidence of 11%, occurring more frequently in females (median age of four yr) and with clinically advanced disease. Monomorphic PTLD was the most common histological subtype. There was a significant difference in the use of ATG between patients who developed PTLD and those who did not (p < 0.01); a similar difference was seen with the use of sirolimus (p < 0.001). These results suggested a link between the combination of ATG and sirolimus and development of more clinically and histologically advanced PTLD; however, the risk of ATG by itself was not clear. EBV viral loads were higher in patients with PTLD, and median time between detection of EBV to PTLD diagnosis was three months. However, viral loads at the time of PTLD diagnosis were most often lower than at EBV detection, thereby raising questions on the correlation between decreasing viral genomes and risk of PTLD.

DOI: 10.1111/petr.12150

Cite this paper

@article{Nassif2013ClinicopathologicFO, title={Clinicopathologic features of post-transplant lymphoproliferative disorders arising after pediatric small bowel transplant.}, author={Sani R. Nassif and Stuart S. Kaufman and Sahar Vahdat and Nada A. Yazigi and Bhaskar Kallakury and Easter Island and Metin Ozdemirli}, journal={Pediatric transplantation}, year={2013}, volume={17 8}, pages={765-73} }